RESEARCH ALERT-First Albany ups SuperGen to  quot;buy quot; on drug deal First Albany Capital on Wednesday raised SuperGen Inc. #39;s (SUPG.O: Quote, Profile, Research) stock rating to  quot;buy quot; from  quot;neutral, quot; following its cancer-drug deal with MGI Pharma Inc.